We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
(+7.6%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$218M |
| 2 |
Parker-Hannifin
PH
|
+$155M |
| 3 |
Illumina
ILMN
|
+$80.7M |
| 4 |
Walt Disney
DIS
|
+$74.2M |
| 5 |
AZEK
The AZEK Co
AZEK
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$819M |
| 2 |
Meta Platforms (Facebook)
META
|
+$338M |
| 3 |
Microsoft
MSFT
|
+$131M |
| 4 |
Amazon
AMZN
|
+$106M |
| 5 |
Salesforce
CRM
|
+$93.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.29% |
| 2 | Communication Services | 16.35% |
| 3 | Consumer Discretionary | 16.22% |
| 4 | Healthcare | 12.62% |
| 5 | Financials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
CVS Health
CVS
$122B
| $431K | ﹤0.01% |
6,234
+1,574
| +34% | +$112K |
|
452
Axcelis
ACLS
$4.1B
| $429K | ﹤0.01% |
+2,338
| New | +$337K |
|
453
Marathon Petroleum
MPC
$90B
| $425K | ﹤0.01% |
3,649
-24
| -0.7% | -$2.79K |
|
454
Dynatrace
DT
$14.6B
| $422K | ﹤0.01% |
8,197
+6,819
| +495% | +$320K |
|
455
Automatic Data Processing
ADP
$109B
| $405K | ﹤0.01% |
1,844
-1,653
| -47% | -$356K |
|
456
MetLife
MET
$61.7B
| $387K | ﹤0.01% |
6,842
+5,497
| +409% | +$305K |
|
457
Direxion Auspice Broad Commodity Strategy ETF
COM
$207M
| $383K | ﹤0.01% |
13,024
-602
| -4% | -$18.6K |
|
458
Uber
UBER
$159B
| $383K | ﹤0.01% |
+8,877
| New | +$330K |
|
459
AutoZone
AZO
$50.1B
| $372K | ﹤0.01% |
149
+77
| +107% | +$196K |
|
460
Lowe's Companies
LOW
$123B
| $366K | ﹤0.01% |
1,620
+296
| +22% | +$61.6K |
|
461
Elastic
ESTC
$7.93B
| $361K | ﹤0.01% |
5,630
+565
| +11% | +$35.4K |
|
462
DexCom
DXCM
$33.1B
| $360K | ﹤0.01% |
2,804
+2,185
| +353% | +$264K |
|
463
Fair Isaac
FICO
$22.7B
| $353K | ﹤0.01% |
436
+427
| +4,744% | +$320K |
|
464
Twilio
TWLO
$38B
| $353K | ﹤0.01% |
+5,555
| New | +$328K |
|
465
Chevron
CVX
$382B
| $340K | ﹤0.01% |
2,158
+1,568
| +266% | +$251K |
|
466
VeriSign
VRSN
$26.5B
| $333K | ﹤0.01% |
+1,474
| New | +$325K |
|
467
iShares Core US Aggregate Bond ETF
AGG
$137B
| $320K | ﹤0.01% |
+3,266
| New | +$323K |
|
468
TransDigm Group
TDG
$67.6B
| $308K | ﹤0.01% |
+344
| New | +$272K |
|
469
PepsiCo
PEP
$188B
| $306K | ﹤0.01% |
1,653
-1,881
| -53% | -$351K |
|
|
DOCU
470
DocuSign
DOCU
$11.4B
| $303K | ﹤0.01% |
+5,925
| New | +$314K |
|
471
Okta
OKTA
$26.2B
| $295K | ﹤0.01% |
+4,251
| New | +$323K |
|
472
Interactive Brokers
IBKR
$41.1B
| $288K | ﹤0.01% |
13,860
+13,344
| +2,586% | +$263K |
|
473
Advanced Micro Devices
AMD
$767B
| $285K | ﹤0.01% |
2,506
-6,416
| -72% | -$667K |
|
474
Intuit
INTU
$91.5B
| $280K | ﹤0.01% |
612
+148
| +32% | +$64.8K |
|
475
Unilever
UL
$135B
| $273K | ﹤0.01% |
4,658
-28
| -0.6% | -$1.66K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2023 Portfolio in Review
As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.
- Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
- Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
- Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
- Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
- Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
- Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
- Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.